Zofran® demonstrou eficácia no controle de náuseas e vômitos em 75% dos pacientes tratados com quimioterapia com cisplatina.1
1 MARTY M. et al. Comparison of the 5-hydroxytryptamine3 (serotonin) antagonist ondansetron (GR 38032F) with high-dose metoclopramide in the control ofcisplatin-induced emesis. N Engl J Med, 32;322(12): 816-21, 1990.